GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sewoonmedical Co Ltd (XKRX:100700) » Definitions » Piotroski F-Score

Sewoonmedical Co (XKRX:100700) Piotroski F-Score : 5 (As of Apr. 17, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Sewoonmedical Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sewoonmedical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Sewoonmedical Co's Piotroski F-Score or its related term are showing as below:

XKRX:100700' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Sewoonmedical Co was 8. The lowest was 3. And the median was 6.


Sewoonmedical Co Piotroski F-Score Historical Data

The historical data trend for Sewoonmedical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sewoonmedical Co Piotroski F-Score Chart

Sewoonmedical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 7.00 3.00 8.00 5.00

Sewoonmedical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 7.00 7.00 5.00 5.00

Competitive Comparison of Sewoonmedical Co's Piotroski F-Score

For the Medical Devices subindustry, Sewoonmedical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sewoonmedical Co's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sewoonmedical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sewoonmedical Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 3756.26 + 2945.358 + 2321.073 + 3139.9 = ₩12,163 Mil.
Cash Flow from Operations was 4994.947 + 1657.874 + 2672.111 + 3860.714 = ₩13,186 Mil.
Revenue was 14839.48 + 15282.449 + 14971.152 + 15057.874 = ₩60,151 Mil.
Gross Profit was 6117.828 + 5704.604 + 5205.234 + 5160.232 = ₩22,188 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(146611.653 + 151694.779 + 149708.582 + 150632.577 + 156848.128) / 5 = ₩151099.1438 Mil.
Total Assets at the begining of this year (Dec23) was ₩146,612 Mil.
Long-Term Debt & Capital Lease Obligation was ₩772 Mil.
Total Current Assets was ₩119,381 Mil.
Total Current Liabilities was ₩7,010 Mil.
Net Income was 3863.791 + 3650.037 + 4581.201 + 2861.892 = ₩14,957 Mil.

Revenue was 15881.266 + 17612.549 + 18003.274 + 16749.845 = ₩68,247 Mil.
Gross Profit was 6459.402 + 6911.37 + 7776.147 + 6410.538 = ₩27,557 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(132478.68 + 138154.288 + 139945.526 + 144447.099 + 146611.653) / 5 = ₩140327.4492 Mil.
Total Assets at the begining of last year (Dec22) was ₩132,479 Mil.
Long-Term Debt & Capital Lease Obligation was ₩622 Mil.
Total Current Assets was ₩107,929 Mil.
Total Current Liabilities was ₩8,297 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sewoonmedical Co's current Net Income (TTM) was 12,163. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sewoonmedical Co's current Cash Flow from Operations (TTM) was 13,186. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=12162.591/146611.653
=0.08295787

ROA (Last Year)=Net Income/Total Assets (Dec22)
=14956.921/132478.68
=0.11290059

Sewoonmedical Co's return on assets of this year was 0.08295787. Sewoonmedical Co's return on assets of last year was 0.11290059. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sewoonmedical Co's current Net Income (TTM) was 12,163. Sewoonmedical Co's current Cash Flow from Operations (TTM) was 13,186. ==> 13,186 > 12,163 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=772.041/151099.1438
=0.0051095

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=621.619/140327.4492
=0.00442977

Sewoonmedical Co's gearing of this year was 0.0051095. Sewoonmedical Co's gearing of last year was 0.00442977. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=119380.519/7009.932
=17.03019644

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=107929.06/8297.259
=13.00779691

Sewoonmedical Co's current ratio of this year was 17.03019644. Sewoonmedical Co's current ratio of last year was 13.00779691. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sewoonmedical Co's number of shares in issue this year was 42.998. Sewoonmedical Co's number of shares in issue last year was 43.36. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=22187.898/60150.955
=0.36887025

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=27557.457/68246.934
=0.4037904

Sewoonmedical Co's gross margin of this year was 0.36887025. Sewoonmedical Co's gross margin of last year was 0.4037904. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=60150.955/146611.653
=0.41027404

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=68246.934/132478.68
=0.51515409

Sewoonmedical Co's asset turnover of this year was 0.41027404. Sewoonmedical Co's asset turnover of last year was 0.51515409. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sewoonmedical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Sewoonmedical Co  (XKRX:100700) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sewoonmedical Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sewoonmedical Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sewoonmedical Co Business Description

Traded in Other Exchanges
N/A
Address
60 Dorim-gil, Ipjang-myeon, Seobuk-gu, Chungcheongnam-Do, Cheonan, KOR
Sewoonmedical Co Ltd engages in the research and development, manufacture, and sale of medical products in South Korea. It provides wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products.

Sewoonmedical Co Headlines

No Headlines